Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade. [electronic resource] by
- Choi, Eun-Sun
- Oh, Sejun
- Jang, Boonsil
- Yu, Hyun-Ju
- Shin, Ji-Ae
- Cho, Nam-Pyo
- Yang, In-Hyoung
- Won, Dong-Hoon
- Kwon, Hye-Jeong
- Hong, Seong Doo
- Cho, Sung-Dae
Producer: 20180806
In:
Cellular oncology (Dordrecht, Netherlands) vol. 40
Availability: No items available.
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
|